Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase.

Singh, Shilpi; Maurya, Akhilesh Kumar; Meena, Abha; Mishra, Nidhi; Luqman, Suaib

Singh, Shilpi; Maurya, Akhilesh Kumar; Meena, Abha; Mishra, Nidhi; Luqman, Suaib.

Afiliación

Singh S; Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
Maurya AK; Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India.
Meena A; Department of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, India.
Mishra N; Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
Luqman S; Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India.

J Biomol Struct Dyn ; : 1-12, 2023 Sep 21.

Article en En | MEDLINE | ID: mdl-37732353

Palabras clave

MD simulation; Myricetin 3-rhamnoside; breast cancer; hyaluronidase; in silico molecular docking; ornithine decarboxylase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Biomol Struct Dyn Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google